Grassmann; Olaf

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grassmann; Olaf.The latest application filed is for "synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene and crytalline forms thereof".

Company Profile

3.11.23

Grassmann; Olaf - Loerrach DE
GRASSMANN; Olaf - Basel CH
Grassmann; Olaf - Kandern DE
Grassmann; Olaf - Lorrach DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And Crytalline Forms Thereof App 20210284648 - Rothenhaeusler; Benno ; et al.	2021-09-16
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H- -2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof Grant 11,040,977 - Rothenhaeusler , et al. June 22, 2	2021-06-22
Compositions For Treating Spinal Muscular Atrophy App 20200323856 - ALSENZ; Jochem ; et al.	2020-10-15
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And App 20190194210 - Rothenhaeusler; Benno ; et al.	2019-06-27
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H- -2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof Grant 10,246,460 - Rothenhaeusler , et al.	2019-04-02
Compositions For Treating Spinal Muscular Atrophy App 20180289712 - Alsenz; Jochem ; et al.	2018-10-11
Solid Forms Of (s)-2-methoxy-3--propionic Acid And Of Salts Thereof App 20170281602 - Dreier; Lukas ; et al.	2017-10-05
Process to manufacture N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]aceta- mide Grant 9,562,009 - Grassmann , et al. February 7, 2	2017-02-07
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And Crytalline Forms Thereof App 20160280712 - Rothenhaeusler; Benno ; et al.	2016-09-29
Process To Manufacture N-[(3s)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]aceta- Mide App 20160237032 - Grassmann; Olaf ; et al.	2016-08-18
Solid forms Grant 8,975,397 - Dott , et al. March 10, 2	2015-03-10
Novel Solid Forms App 20140329806 - Dott; Pascal ; et al.	2014-11-06
Solid forms Grant 8,785,435 - Dott , et al. July 22, 2	2014-07-22
New Solid Forms of [4-(3-Fluoro-5-Trifluoromethyl-Pyridin-2-Yl)-Piperazin-1-Yl-[5-Methanesul- fonyl-2-((S)-2,2,2-Trifluoro-1-Methyl-Ethoxy)-Phenyl]Methanone App 20130197225 - Bubendorf; Andre ; et al.	2013-08-01
Novel Solid Forms App 20130172329 - Dott; Pascal ; et al.	2013-07-04
Polymorphic forms of oseltamivir phosphate Grant 8,334,319 - Goldbach , et al. December 18, 2	2012-12-18
Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyr- idine Grant 8,329,912 - Cleary , et al. December 11, 2	2012-12-11
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20120309969 - Bubendorf; Andre ; et al.	2012-12-06
Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyr- idine App 20120035222 - Cleary; Thomas ; et al.	2012-02-09
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20110295007 - Bubendorf; Andre ; et al.	2011-12-01
Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyr- idine Grant 8,063,076 - Cleary , et al. November 22, 2	2011-11-22
Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- fonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone Grant 8,039,473 - Bubendorf , et al. October 18, 2	2011-10-18
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20100311971 - Bubendorf; Andre ; et al.	2010-12-09
Salt and polymorphs of a DPPIV inhibitor Grant 7,772,264 - Abrecht , et al. August 10, 2	2010-08-10
Salt And Polymorph Of A Dpp-iv Inhibitor App 20100093808 - Bubendorf; Andre ; et al.	2010-04-15
Sample Carrier App 20100068100 - Voegelin; Dieter ; et al.	2010-03-18
Solid Forms Of A Pyrrolidine-3,4-dicarboxamide Derivative App 20090215826 - Adam; Jean-Michel ; et al.	2009-08-27
Polymorphic Forms of Oseltamivir Phosphate App 20090176886 - Bubendorf; Andre ; et al.	2009-07-09
Solid Forms Of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl]-pyr- Idine App 20080312288 - Cleary; Thomas ; et al.	2008-12-18
Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone App 20080214561 - Bubendorf; Andre ; et al.	2008-09-04
Methods of transmission mode X-ray diffraction analysis and apparatuses therefor Grant 7,409,041 - Grassmann , et al. August 5, 2	2008-08-05
New salt and polymorph of a DPP-IV inhibitor App 20070142436 - Bubendorf; Andre ; et al.	2007-06-21
Methods of transmission mode x-ray diffraction analysis and apparatuses therefor App 20060245544 - Grassmann; Olaf ; et al.	2006-11-02
Salt and polymorphs of a DPPIV inhibitor App 20060217428 - Abrecht; Stefan ; et al.	2006-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.